Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
ZYNTEGLO is a first-in-class, one-time ex vivo LVV gene addition therapy from Ge...
A study showed that restoring cellular vibration reduces the aggressiveness of a...
The breakthrough came with the development of chiral, zwitterionic organoboron c...
Atrium has identified two lead candidates: ATR 1072, a treatment for protein kin...
Researchers found that, measured in blood samples, the biomarker p-tau217 was st...
In this GEN Learning Lab, our expert panelists Linda Orzolek, MS, MB, Xuhuai Ji,...
With GLP-1 manufacturing consuming a growing share of global peptide capacity, N...
Most zoonotic viruses do not show evidence that acquiring adaptive mutations is ...
Studies in mice identified a role for resident tissue macrophages in maintaining...
CD71, a protein involved in iron transport, is highly expressed across leukemia ...
With health care affordability a top concern for many Americans, pharmacy benefi...
As climate pressure mounts, new platforms tackle delivery, regulation, trait sta...
Therapeutic developers are increasingly rebuilding their workflows around AI to ...
A 4D whole-cell simulation of the minimal bacterium JCVI-syn3A models DNA replic...
The cell line is designed for reliability, with more than 90 percent of evaluate...
AI is no longer a futuristic add-on in the life sciences. It is rapidly becoming...